The USFDA inspection planned between 4th March, 2024 to 8th March, 2024 at the Dishman Carbogen Amcis Limited's facility in Bavla, Ahmedabad, was successfully completed on 7th March, 2024.

The inspection was concluded with few procedural observations and the same will be addressed within the stipulated timelines.

No any serious issue was raised during the course for the entire inspection.

Thus, the company's facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the US FDA.